Darren Gitelman
Advanced in Cerebellar Degeneration

Dr. Darren Gitelman

Psychology
Aurora Healthcare
Advocate Memory Center
1875 Dempster St, Ste 520, 
Park Ridge, IL 
On Staff At
Offers Telehealth

Advanced in Cerebellar Degeneration
Aurora Healthcare
Advocate Memory Center
1875 Dempster St, Ste 520, 
Park Ridge, IL 
OverviewInsuranceLocationsClinical Research

Overview

Darren Gitelman is a Psychologist in Park Ridge, Illinois. Dr. Gitelman is rated as an Advanced provider by MediFind in the treatment of Cerebellar Degeneration. His top areas of expertise are Alzheimer's Disease, Dementia, Cerebellar Degeneration, and Memory Loss.

His clinical research consists of co-authoring 30 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Residency
Massachusetts General Hospital - Harvard Medical School, Neurology
Specialties
Psychology
Licenses
Psychiatry & Neurology in WI
Board Certifications
American Board Of Internal Medicine
Fellowships
Beth Israel Hospital, Behavioral Neurology
Hospital Affiliations
Advocate Lutheran General Hospital
Advocate Condell Medical Center
Advocate Christ Hospital & Medical Center
Advocate Illinois Masonic Medical Center
Advocate Good Samaritan Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 10 Less Insurance Carriers -

Locations

Advocate Memory Center
1875 Dempster St, Ste 520, Park Ridge, IL 60068
Call: 847-720-6464
Other Locations
Advocate Medical Group Behavioral Neurology
2210 W 95th St, Chicago, IL 60643

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease
A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: November 12, 2025
Intervention Type: Drug
Study Drugs: Gantenerumab, Solanezumab
Study Phase: Phase 2/Phase 3
U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk
U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk
Enrollment Status: Completed
Publish Date: November 03, 2025
Intervention Type: Behavioral
Study Phase: Not Applicable
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 29, 2025
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease
A Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease
Enrollment Status: Completed
Publish Date: August 26, 2022
Intervention Type: Drug
Study Drug: Tilavonemab
Study Phase: Phase 2
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: September 02, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gitelman's expertise for a condition
ConditionClose
    • Distinguished
    • Alzheimer's Disease
      Dr. Gitelman is
      Distinguished
      . Learn about Alzheimer's Disease.
      See more Alzheimer's Disease experts
    • Dementia
      Dr. Gitelman is
      Distinguished
      . Learn about Dementia.
      See more Dementia experts
    • Advanced
    • Cerebellar Degeneration
      Dr. Gitelman is
      Advanced
      . Learn about Cerebellar Degeneration.
      See more Cerebellar Degeneration experts
    • Lewy Body Dementia (LBD)
      Dr. Gitelman is
      Advanced
      . Learn about Lewy Body Dementia (LBD).
      See more Lewy Body Dementia (LBD) experts
    • Memory Loss
      Dr. Gitelman is
      Advanced
      . Learn about Memory Loss.
      See more Memory Loss experts
    • Neuronal Intranuclear Inclusion Disease (NIID)
      Dr. Gitelman is
      Advanced
      . Learn about Neuronal Intranuclear Inclusion Disease (NIID).
      See more Neuronal Intranuclear Inclusion Disease (NIID) experts
    • Experienced
    • Adult Polyglucosan Body Disease
      Dr. Gitelman is
      Experienced
      . Learn about Adult Polyglucosan Body Disease.
      See more Adult Polyglucosan Body Disease experts
    • Apraxia
      Dr. Gitelman is
      Experienced
      . Learn about Apraxia.
      See more Apraxia experts
    • Cardiac Amyloidosis
      Dr. Gitelman is
      Experienced
      . Learn about Cardiac Amyloidosis.
      See more Cardiac Amyloidosis experts
    • Cerebellar Multiple System Atrophy
      Dr. Gitelman is
      Experienced
      . Learn about Cerebellar Multiple System Atrophy.
      See more Cerebellar Multiple System Atrophy experts
    • Cerebral Amyloid Angiopathy
      Dr. Gitelman is
      Experienced
      . Learn about Cerebral Amyloid Angiopathy.
      See more Cerebral Amyloid Angiopathy experts
    • Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
      Dr. Gitelman is
      Experienced
      . Learn about Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy.
      See more Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy experts
    View All 27 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.